Typhoid Vaccine Market Report 2024 (Global Edition)

Global Typhoid Vaccine Market Report 2024 Market Size Split by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, Others), by Route of Administration (Oral, Inj...

Typhoid Vaccine Market Report Description

We have various report editions of Typhoid Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Typhoid Vaccine Market

The competitive landscape of the Typhoid Vaccine market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Typhoid Vaccine companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

Top Companies Market Share in Typhoid Vaccine Industry: (In no particular order of Rank)

• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd
• Sanofi
• AstraZeneca
• Johnson & Johnson Private Limited
• Merck & Co.
• F. Hoffmann-La Roche Ltd.
• bioMérieux SA
• Amgen Inc.
• Takeda Pharmaceutical Company Limited
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Typhoid Vaccine Market

Which Region Dominates the Typhoid Vaccine Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. The North American typhoid vaccine marketplace is experiencing an increase driven by factors that include a growing journey to endemic regions, rising awareness of travel-associated fitness risks, and expanding vaccination initiatives. Additionally, efforts to decorate healthcare infrastructure and vaccination insurance make a contribution to market expansion. The place's cognizance of preventive healthcare measures further propels the call for typhoid vaccines.

Which Region is Expanding at the Fastest CAGR?

Europe stands out as the fastest-growing region in the Typhoid Vaccine market due to several compelling reasons. ? The European typhoid vaccine market is experiencing a boom due to rising awareness of journey-associated fitness dangers and increasing vaccination efforts. Expanded travel to endemic regions and a proactive approach to preventive healthcare contribute to marketplace growth. Efforts to reinforce healthcare infrastructure and vaccination campaigns similarly bolster the demand for typhoid vaccines within the region.

The current report Scope analyzes Typhoid Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Typhoid Vaccine

According to Cognitive Market Research, the global Typhoid Vaccine market size was estimated at USD 361.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 144.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Typhoid Vaccine market with a market size of USD 113.99 million in 2024 and is projected to grow at a CAGR of 11.0% during the forecast period. The demand is amplified by the travel medicine.
• The Canada Typhoid Vaccine market had a market share of USD 17.34 million in 2024 and is projected to grow at a CAGR of 12.0% during the forecast period. Canada's disease outbreaks.
• The Mexico Typhoid Vaccine market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 13.15 million in 2024.

Europe Typhoid Vaccine

According to Cognitive Market Research, the global Typhoid Vaccine market size was estimated at USD 361.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 108.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

• The United Kingdom Typhoid Vaccine market had a market share of USD 18.20 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. In the UK, Typhoid Vaccine sales witness an upswing due to the immunization campaigns.
• The France Typhoid Vaccine market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 9.97 million in 2024.
• According to Cognitive Market Research, the Germany Typhoid Vaccine market size was valued at USD 21.46 million in 2024 and is projected to grow at a CAGR of 11.7% during the forecast period. In Germany, Typhoid Vaccine sales surged due to the healthcare infrastructure.
• The Italy Typhoid Vaccine market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 9.32 million in 2024.
• The Russia Typhoid Vaccine market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 16.80 million in 2024.
• The Spain Typhoid Vaccine market is projected to witness growth at a CAGR of 10.6% during the forecast period with a market size of USD 8.89 million in 2024
• The Luxembourg Typhoid Vaccine market is projected to witness growth at a CAGR of 11.6% during the forecast period, with a market size of USD 3.36 million in 2024.
• The Portugal Typhoid Vaccine market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 2.28 million in 2024.
• The Greece Typhoid Vaccine market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 1.30 million in 2024.
• Rest of Europe's Typhoid Vaccine market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 16.80 million in 2024.

Asia Pacific Typhoid Vaccine

According to Cognitive Market Research, the global Typhoid Vaccine market size was estimated at USD 361.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 83.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.0% from 2024 to 2031

• According to Cognitive Market Research, the China Typhoid Vaccine market size was valued at USD 37.38 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. Typhoid Vaccine sales surge in China due to the global health initiatives.
• The Japan Typhoid Vaccine market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 11.46 million in 2024.
• The India Typhoid Vaccine market had a market share of USD 9.97 million in 2024 and is projected to grow at a CAGR of 16.8% during the forecast period. India's research funding.
• The South Korea Typhoid Vaccine market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 8.31 million in 2024.
• The Australia Typhoid Vaccine market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 4.32 million in 2024.
• The South East Asia Typhoid Vaccine market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 5.73 million in 2024.
• The Rest of Asia Pacific Typhoid Vaccine market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 5.90 million in 2024.

South America Typhoid Vaccine

According to Cognitive Market Research, the global Typhoid Vaccine market size was estimated at USD 361.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 18.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Typhoid Vaccine market size was valued at USD 7.73 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period. Typhoid Vaccine sales flourish in Brazil due to the epidemiological surveillance.
• Argentina Typhoid Vaccine market had a market share of USD 3.03 million in 2024 and is projected to grow at a CAGR of 13.3% during the forecast period. Argentina's vaccine access programs.
• Colombia Typhoid Vaccine market is projected to witness growth at a CAGR of 12.2% during the forecast period with a market size of USD 31.61 million in 2024.
• Peru Typhoid Vaccine market is projected to witness growth at a CAGR of 12.6% during the forecast period with a market size of USD 1.48 million in 2024.
• Chile Typhoid Vaccine market is projected to witness growth at a CAGR of 12.7% during the forecast period with a market size of USD 1.30 million in 2024.
• The Rest of Latin America Typhoid Vaccine market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 2.91 million in 2024.

Middle East and Africa Typhoid Vaccine

According to Cognitive Market Research, the global Typhoid Vaccine market size was estimated at USD 361.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 7.22 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.7% from 2024 to 2031.

• The GCC Countries Typhoid Vaccine market is projected to witness growth at a CAGR of 13.5% during the forecast period with a market size of USD 3.09 million in 2024. Typhoid Vaccine sales flourish due to the drug development.
• The Egypt Typhoid Vaccine market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 0.76 million in 2024.
• The South Africa Typhoid Vaccine market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 1.14 million in 2024. Typhoid Vaccine sales flourish in South Africa due to the public health policies.
• The Turkey Typhoid Vaccine market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 0.62 million in 2024.
• The Nigeria Typhoid Vaccine market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 0.76 million in 2024.
• The Rest of MEA Typhoid Vaccine market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 0.85 million in 2024.

Typhoid Vaccine Market Analysis

Typhoid Vaccine Market Vaccine Type Segment Analysis

According to Cognitive Market Research, Live Attenuated Vaccine stands out as the dominating category. The stay-attenuated typhoid vaccine section is riding growth within the typhoid vaccine market because of its effectiveness and comfort. With strong immune response elicitation and longer-lasting safety, this vaccine type is increasingly preferred by healthcare providers and travelers alike. Expanded availability, coupled with rising attention to its benefits, contributes to the section's prominence in preventing typhoid fever globally.

Capsular Polysaccharide Vaccine emerges as the fastest-growing category in the Typhoid Vaccine market. The Capsulated Polysaccharide Vaccine segment is fueling an increase within the typhoid vaccine marketplace attributable to its efficacy and protection profile. Widely endorsed for vacationers and people in endemic areas, this vaccine type provides reliable safety against typhoid fever. Increasing awareness of its benefits, coupled with improved accessibility, drives demand for this vaccine, positioning it as a key contributor to market enlargement.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Typhoid Vaccine Industry. Request a Free Sample PDF!

Typhoid Vaccine Market Route of Administration Segment Analysis

According to Cognitive Market Research, the dominating category is Oral. The Oral typhoid vaccine segment is growing in the marketplace due to its ease of management and suitability for mass vaccination campaigns. Offering convenience and cost-effectiveness, this vaccine type is increasingly favored by travelers and endemic populations. Expanded availability and regulatory approvals similarly propel the segment's growth, positioning oral vaccines as a critical tool in preventing typhoid fever worldwide.

The fastest-growing category in the Typhoid Vaccine market is Injection. The Injection typhoid vaccine section is experiencing growth within the market due to its hooked-up efficacy and massive use. Preferred for their excessive immunogenicity and long-lasting safety, injection vaccines are increasingly fashionable among healthcare providers and tourists. Growing cognizance of the significance of vaccination, coupled with expanding vaccination campaigns, drives the call for injection vaccines, contributing to marketplace growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Typhoid Vaccine End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals and Clinics. Hospitals and clinics are pivotal in using growth within the typhoid vaccine marketplace with the aid of serving as key distribution points and vaccination centers. With growing attention on preventive healthcare, those facilities play an important function in elevating awareness approximately typhoid vaccination and administering vaccines to individuals, such as tourists and those living in endemic areas. Their accessibility and understanding contribute substantially to marketplace enlargement.

The fastest-growing category in the Typhoid Vaccine market is Specialty Centers. Specialty centers are emerging as widespread members of the increase of the typhoid vaccine marketplace. These facilities, geared up with specialized know-how and resources, cater to particular healthcare desires, which include journey remedies and infectious diseases. With a focus on centered vaccination offerings and tailored pointers, unique facilities play a vital role in growing attention and getting admission to typhoid vaccines, using marketplace enlargement on this area of interest segment.

• Hospitals and Clinics
• Specialty Centers
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion